Resources

Personalized Medicine at FDA: The Scope & Significance of Progress in 2019


Personalized Medicine at FDA: The Scope & Significance of Progress in 2019 explains how 12 personalized treatments and seven diagnostics the U.S. Food and Drug Administration (FDA) approved or cleared in 2019 will improve patient care and make the health system more efficient by addressing root causes of rare diseases, expanding treatment options for cancer patients, and targeting therapies to responder populations. The approvals and clearance decisions expand the frontiers of the rapidly evolving field of personalized medicine for the benefit of patients and health systems.

Join Today

PMC members shape and advance the future of personalized medicine.
Join Today